Enhancing pigmentation via activation of A3 adenosine receptors in B16 melanoma cells and in human skin explants

Experimental Dermatology

Volumn 22, Issue 1, 2013, Pages 74-77

  Madi, Lea ^a   Rosenberg Haggen, Bianca ^b   Nyska, Abraham ^a   Korenstein, Rafi ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Misgav Ladach General Hospital Israel   (Israel)

Author keywords

Melanin; Melanocyte; MiTF; PI3K; Skin

Indexed keywords

A3 ADENOSINE RECEPTOR; ADENOSINE RECEPTOR; CATECHOL OXIDASE; CYCLIC AMP; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MELANIN; PROTEIN KINASE B; UNCLASSIFIED DRUG;

DOWN REGULATION; EXPLANT; HUMAN; HYPERPIGMENTATION; LETTER; MELANOGENESIS; MELANOMA; MELANOMA CELL; PROTEIN PHOSPHORYLATION; SKIN PIGMENTATION;

ADENOSINE; ANDROSTADIENES; CELL LINE, TUMOR; CYCLIC AMP; DIHYDROXYPHENYLALANINE; HUMANS; KERATINOCYTES; MAP KINASE SIGNALING SYSTEM; MELANOMA, EXPERIMENTAL; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PIGMENTATION; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ADENOSINE A3; SKIN; SKIN NEOPLASMS;

EID: 84871711982     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12028     Document Type: Letter

References (24)

1. Plonka P M, Passeron T, Brenner M et al. Exp Dermatol 2009: 18: 799-819.
2. Slominski A, Tobin D J, Shibahara S et al. Physiol Rev 2004: 84: 1155-1228.
3. Vachtenheim J, Borovansky J. Exp Dermatol 2010: 19: 617-627.
4. Chou T H, Ding H Y, Hung W J et al. Exp Dermatol 2010: 19: 742-750.
5. Liang C H. Exp Dermatol 2011: 20: 743-748.
6. Englaro W, Bertolotto C, Busca R et al. J Biol Chem 1998: 273: 9966-9970.
7. Lee M S, Yoon H D, Kim J I et al. Exp Dermatol 2012: 21: 471-473.
8. Hunt G, Todd C, Cresswell J E et al. J Cell Sci 1994: 107 (Pt 1): 205-211.
9. Im S, Moro O, Peng F et al. Cancer Res 1998: 58: 47-54.
10. Wong G, Pawelek J. Nature 1975: 255: 644-646.
11. Kang Y G, Choi E J, Choi Y et al. Exp Dermatol 2011: 20: 445-447.
12. Jung E, Hwang W, Kim S et al. Exp Dermatol 2011: 20: 986-991.
13. Choi M Y, Song H S, Hur H S et al. Arch Pharm Res 2008: 31: 1166-1171.
14. Lee H D, Lee W H, Roh E et al. Exp Dermatol 2011: 20: 761-763.
15. Levy C, Fisher D E. Transcription 2011: 2: 19-22.
16. Tassabehji M, Newton V E, Read A P. Nat Genet 1994: 8: 251-255.
17. Fredholm B B, IJzerman A P, Jacobson K A et al. Pharmacol Rev 2001: 53: 527-552.
18. Linden J. Annu Rev Pharmacol Toxicol 2001: 41: 775-787.
19. Madi L, Bar-Yehuda S, Barer F et al. J Biol Chem 2003: 278: 42121-42130.
20. Merighi S, Benini A, Mirandola P et al. J Biol Chem 2005: 280: 19516-19526.
21. Gibbs S, Murli S, De Boer G et al. Pigment Cell Res 2000: 13: 458-466.
22. Gao Z, Li B S, Day Y J et al. Mol Pharmacol 2001: 59: 76-82.
23. Kawasaki A, Kumasaka M, Satoh A et al. Pigment Cell Melanoma Res 2008: 21: 56-62.
24. Kovacs S O. J Am Acad Dermatol 1998: 38: 647-666; quiz 667-648.